Results 141 to 150 of about 21,593,154 (307)
Change in Mental Health and Resilience in Childhood Cancer Survivors After Attending a Person‐Centred State‐of‐the‐Art Late Effects Clinic—on Behalf of the PanCareFollowUp Consortium
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Person‐centred follow‐up care based on evidence‐based clinical practice guidelines and providing individualised information should help to inform and reassure survivors about their medical and psychosocial situation and provide treatment and support where needed.Gisela Michel, Mieke Rijken, Marietta Kokla, Charlotte Sleurs, Jurgen Lemiere, Line Elmerdahl Frederiksen, Luzius Mader, Cecilia Follin, Sara Oberti, Jeanette Falck Winther, Selina R. van den Oever, Leontien C. M. Kremer, Helena J. H. van der Pal, Peter Spreeuwenberg, Eline Bouwman, Jeroen te Dorsthorst, Samira Essiaf, Elizabeth A. M. (Lieke) Feijen, Hannah Gsell, Riccardo Haupt, Maria van Helvoirt, Rosella P. M. G. Hermens, Lars Hjorth, Tomas Kepak, Katerina Kepakova, Anita Kienesberger, Monica Muraca, Marleen Renard, Carina Schneider, Roderick Skinner, Anne Uyttebroeck, Deveny Vanrusselt, Sabine Verschueren, Jacqueline Loonen, Saskia M. F. Pluijm, Katharina Roser, the PanCareFollowUp consortium +36 morewiley +1 more sourceSecretory Phospholipase A2 in Patients With Sickle Cell Disease Hospitalized for Vaso‐Occlusive Pain Episodes
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.Rawan Korman, Maria Yasmine, Dunia Hatabah, Noor Alzraikat, Frank Harris, Lou Ann Brown, Satheesh Chonat, Nitya Bakshi, Chris A. Rees, Carlton Dampier, Claudia R. Morris +10 morewiley +1 more sourceA Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background
Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...Yuh‐Shan Ho, Karim M. Soliman, Wisit Cheungpasitporn, Wannasit Wathanavasin, Ahmed Daoud, Ahmed I. Kamal, Balázs Szamosfalvi, Tibor Fülöp +7 morewiley +1 more sourceTherapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background
Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun +33 morewiley +1 more sourceUse of Prokinetic Agents in Adult ICU Patients: An International Inception Cohort Study (PATIENCE). [PDF]
Acta Anaesthesiol ScandCrone V, Møller MH, Granholm A, Perner A, Alhazzani W, Krogsgaard LR, Al-Fares A, Hästbacka J, Ostermann M, Pfortmueller CA, Ferrer R, Blaser AR, Wall O, Keus E, Szczeklik W, Hansen PM, Michelsen J, Bak M, Balkert LS, Severinsen T, Brøchner AC, Pedersen JE, Andreasen AS, Nielsen CT, Itenov TS, Kjær MN, Engbakken Z, Bestle MH, Hjortrup PB, Svendsen CJ, Lindkvist-Viggers S, Brand BA, Jonsson AB, Krogh TB, Jauho KR, Thomsen MS, Straarup TS, Poulsen E, Nissen CG, Breum O, Petersen PL, Torp C, Rasmussen BS, Bunzel AG, Buholzer SF, Hardman E, Törnberg D, Pérez DS, van Smaalen K, Onrust M, Maddison L, Appelberg O, Ehrlich HE, Tamme K, Juhanson R, Korjas J, Jalkanen V, Finni M, Reinikainen M, Koskue T, Czok M, Zatorski P, Doroba O, Kudlinski B, Nowak P, Bialka S, Kluzik A, Baran H, Al Duhailib Z, Hakeam HA, Alshahrani M, Elfaki OA, Alanazi FA, Aldhahri R, Belkhouja K, Alahmari A, Alsayer RM, Friman O, Balintescu A, Krag M. +79 moreeuropepmc +1 more sourceExperience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction
This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods
Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.Yasutaka Yamauchi, Rie Tanaka, Reona Kawahira, Shingo Nabeta, Kouhei Naoi, Kazuhito Kitajima, Akira Wada, Tomonari Takagi, Norihiko Ohura, Akira Miyamoto +9 morewiley +1 more source